Silence Therapeutics PLC (SLN)
23.38
+0.38
(+1.65%)
USD |
NASDAQ |
May 20, 16:00
23.38
0.00 (0.00%)
After-Hours: 16:15
Silence Therapeutics 1 Year Total Returns (Daily): 322.0% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | 322.0% |
| May 16, 2024 | 284.9% |
| May 15, 2024 | 280.4% |
| May 14, 2024 | 267.0% |
| May 13, 2024 | 261.5% |
| May 10, 2024 | 243.8% |
| May 09, 2024 | 250.9% |
| May 08, 2024 | 250.4% |
| May 07, 2024 | 249.4% |
| May 06, 2024 | 244.9% |
| May 03, 2024 | 253.0% |
| May 02, 2024 | 220.3% |
| May 01, 2024 | 216.9% |
| April 30, 2024 | 226.3% |
| April 29, 2024 | 226.6% |
| April 26, 2024 | 340.9% |
| April 25, 2024 | 369.0% |
| April 24, 2024 | 383.1% |
| April 23, 2024 | 322.3% |
| April 22, 2024 | 322.1% |
| April 19, 2024 | 242.3% |
| April 18, 2024 | 253.5% |
| April 17, 2024 | 271.7% |
| April 16, 2024 | 242.7% |
| April 15, 2024 | 233.2% |
| Date | Value |
|---|---|
| April 12, 2024 | 282.2% |
| April 11, 2024 | 263.6% |
| April 10, 2024 | 243.3% |
| April 09, 2024 | 231.8% |
| April 08, 2024 | 238.2% |
| April 05, 2024 | 240.9% |
| April 04, 2024 | 251.7% |
| April 03, 2024 | 243.9% |
| April 02, 2024 | 242.6% |
| April 01, 2024 | 250.0% |
| March 28, 2024 | 160.1% |
| March 27, 2024 | 162.9% |
| March 26, 2024 | 134.9% |
| March 25, 2024 | 137.9% |
| March 22, 2024 | 147.2% |
| March 21, 2024 | 153.4% |
| March 20, 2024 | 154.0% |
| March 19, 2024 | 168.3% |
| March 18, 2024 | 176.0% |
| March 15, 2024 | 149.3% |
| March 14, 2024 | 146.7% |
| March 13, 2024 | 157.4% |
| March 12, 2024 | 181.5% |
| March 11, 2024 | 163.6% |
| March 08, 2024 | 158.5% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-71.78%
Minimum
Jun 14 2022
383.1%
Maximum
Apr 24 2024
-2.73%
Average
-31.52%
Median
1 Year Total Returns (Daily) Benchmarks
| Adaptimmune Therapeutics PLC | -17.16% |
| NuCana PLC | -81.20% |
| TC BioPharm (Holdings) PLC | -93.27% |
| Biodexa Pharmaceuticals Plc | -93.53% |
| Autolus Therapeutics PLC | 48.81% |